The New England Journal of Medicine (NEJM) Publishes Roxadustat China Phase 3 Results for the Treatment of Anemia in Chronic Kidney Disease Patients Receiving Dialysis

Ads

You May Also Like

Galena Biopharma Reports First Quarter 2017 Financial Results

SAN RAMON, Calif., May 10, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ:GALE), a ...

RedHill Biopharma to Present at the 9th Annual BioPharm America International Partnering Conference

TEL-AVIV, Israel, Sept. 01, 2016 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” ...

Sedor Pharmaceuticals Receives Major Milestone Payment

Payment from Xi’an Xintong Pharmaceutical Research Co. anchors opportunity for Sedor portfolio in People’s ...